Core domains measured and reported in recent randomized controlled trials (1–8).
| Domains | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 |
|---|---|---|---|---|---|---|---|---|
| Peripheral arthritis | X | X | X | X | X | X | X | X |
| Skin disease | X | X | X | X | X | X | X | X |
| Enthesitis | X | X | X | X | X | X | X | X |
| Dactylitis | X | X | X | X | X | X | X | X |
| Health-related quality of life | X | X | X | X | X | X | X | X |
| Physical function | X | X | X | X | X | X | X | X |
| Systemic inflammation | X | X | X | X | X | X | X | |
| Structural damage | X | X | X | X | ||||
| Nail disease | X | X | X | X | ||||
| Spine symptoms | X | X | X | |||||
| Fatigue | X | X | X | |||||
| Participation | X |